Kamada Ltd. (TLV:KMDA)
2,302.00
+13.00 (0.57%)
At close: Dec 4, 2025
Kamada Revenue
Kamada had revenue of $47.01M USD in the quarter ending September 30, 2025, with 12.63% growth. This brings the company's revenue in the last twelve months to $174.79M, up 10.36% year-over-year. In the year 2024, Kamada had annual revenue of $160.95M with 12.93% growth.
Revenue (ttm)
$174.79M
Revenue Growth
+10.36%
P/S Ratio
2.29
Revenue / Employee
$416.16K
Employees
420
Market Cap
1.33B ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 160.95M | 18.43M | 12.93% |
| Dec 31, 2023 | 142.52M | 13.18M | 10.19% |
| Dec 31, 2022 | 129.34M | 25.70M | 24.79% |
| Dec 31, 2021 | 103.64M | -29.60M | -22.22% |
| Dec 31, 2020 | 133.25M | 6.06M | 4.76% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 55.55B |
| Danel (Adir Yeoshua) | 2.87B |
| BrainsWay | 162.56M |
| SofWave Medical | 255.13M |
| Bait Bakfar | 107.78M |
| Ilex Medical | 915.05M |
| Novolog (Pharm-Up 1966) | 1.97B |
| InterCure | 243.12M |
Kamada News
- 24 days ago - Kamada (KMDA) is an Incredible Growth Stock: 3 Reasons Why - Nasdaq
- 25 days ago - Kamada Ltd (KMDA) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements - GuruFocus
- 25 days ago - Q3 2025 Kamada Ltd Earnings Call Transcript - GuruFocus
- 25 days ago - Kamada Ltd. (KMDA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 25 days ago - Kamada (KMDA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Nasdaq
- 25 days ago - Kamada (KMDA) Q3 2025 Earnings Call Transcript - The Motley Fool
- 25 days ago - Kamada (KMDA) Misses Q3 Earnings Estimates - Nasdaq
- 25 days ago - Kamada (KMDA) Confirms 2025 Financial Outlook with Strong Growth Expectations - GuruFocus